Published Medical Novel Immune Modulatory Agent Investigators have identified a novel TLR-4 antagonist to treat NEC which is highly effective in animal models. This antagonist is also effective in other TLR4-mediated diseases. By University of Pittsburgh
Published Medical Immunotherapy for IBD Restores gut homeostasis in models of ulcerative colitis By Imperial Innovations
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
